Keyphrases
Adalimumab
100%
Anti-adalimumab Antibodies
100%
Antibody-associated
10%
Clinical Observation
10%
Clinical Significance
10%
Disease Course
10%
Drug Efficacy
10%
Drug Failure
10%
Enzyme-linked Immunosorbent Assay (ELISA)
10%
Inflammatory Bowel Disease
100%
Limit of Detection
10%
Loss of Response
10%
Methodological Bias
10%
Negative Samples
10%
Non-persistent
10%
Odds Ratio
10%
Pharmacologically Active
10%
Radioimmunoassay
30%
Reporter Gene Assay
20%
Serum Samples
10%
Short-term Treatment
10%
Temporal Features
10%
Treatment Duration
10%
Treatment Failure
20%
Medicine and Dentistry
Adalimumab
100%
Clinical Observation
5%
Clinical Significance
5%
Cohort Analysis
5%
Disease Course
5%
Drug Efficacy
5%
Enzyme Immunoassay
5%
False Negative Result
5%
Inflammatory Bowel Disease
5%
Odds Ratio
5%
Patient with Inflammatory Bowel Disease
100%
Radioimmunoassay
15%
Reporter Gene
10%
Treatment Duration
5%
Pharmacology, Toxicology and Pharmaceutical Science
Adalimumab
100%
Cohort Study
5%
Disease Course
5%
Elimination
5%
Enzyme Immunoassay
5%
Inflammatory Bowel Disease
100%
Radioimmunoassay
15%
Neuroscience
Adalimumab
100%
Immunoassay
5%
Inflammatory Bowel Disease
100%
Radioimmunoassay
15%
Reporter Gene
10%
Veterinary Science and Veterinary Medicine
Clinical Significance
33%
Radioimmunoassay
100%